NCT07025785View on ClinicalTrials.gov

Molecular Residual Disease Assessment in a Diverse Population of Patients With Early-stage Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 22, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions

Breast CancerLymph Node Metastasis

Trial Locations (1)

27514

RECRUITING

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors

collaborator

Haystack Oncology, Inc.

UNKNOWN

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT07025785 - Molecular Residual Disease Assessment in a Diverse Population of Patients With Early-stage Breast Cancer | Biotech Hunter | Biotech Hunter